Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
N-Zyme Biomedical develops pepsin inhibitor therapies and drug formulations for reflux diseases such as LPR and GERD.
Stem Pharm's synthetic biomaterials support the optimization of cell expansion.
Alzheon is a clinical-stage biotechnology company that develops treatment for neurodegenerative disorders.
Lumia builds wearable that tracks blood flow to help people understand their bodies, improve well-being, and make proactive health choices.
Illuminant Surgical is building a new way of seeing inside the human body.
Lighthouse Pharma's strategy combines translational insights with considerable clinical experience to understand and treat dementia.
Onward provides SAAS + Rides for older adults & people with disabilities, ensuring access to healthcare, social, & daily needs.
Homecare Hub is an platform which has developed a marketplace that helps patients to find the high quality home care providers.
Amydis is a pharmaceutical company that focuses on developing innovative chemistry to detect diseases.
Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.
Software for Senior Care
Rendever is a research-based virtual reality platform that provides cognitive stimulation, socialization, and therapy for older adults.
RevBio was started with one goal in mind—to end medicine’s 50-year search for a biocompatible bone adhesive.
ADvantage Therapeutics develops therapies to treat neurodegenerative conditions focusing on Alzheimer’s Disease.
BetterAge provides a personalized, web-based program to help individuals improve health and well-being.
SeeInMe develops a digital health platform designed to enhance person-centered coordinated care for care recipients.
Calder Biosciences is a groundbreaking biotechnology and molecular engineering firm developing next generation subunit vaccines
Amissa powers evidence-based perimenopause care with AI-enabled clinical decision support.
Olera is a health and wellness services provider that connects caregivers to service providers in the eldercare industry.
Akava Therapeutics is a small molecule therapeutics that inhibits protein aggregation, enzymes, and cancer for neurodegenerative diseases.
EydisBio is the operator of a biotech platform dedicated to developing medical solutions for cancer and arthritis.
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
Preclinical biotech with deep expertise in functional genomics to map genetic variants and advance a rare disease pipeline led by CB-001.
National Institute on Aging has invested in 67 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institute on Aging's top investment sectors include Health Care, Biotechnology, Medical, Pharmaceutical, Biopharma. The firm invests across 37 different industry categories.
Among tracked funding rounds, Alzheon received $78.8M in a Venture - Series Unknown round. National Institute on Aging's total known invested capital is $362.5M.
National Institute on Aging's average investment size is $5.4M across its portfolio of 67 companies.
Recent National Institute on Aging portfolio additions include N-Zyme Biomedical, Stem Pharm, Alzheon, Lumia, Illuminant Surgical. These companies were founded in 2020 or later.